[
  {
    "title": "Valerian for sleep: a systematic review and meta-analysis",
    "year": 2006,
    "study_type": "Systematic review and meta-analysis",
    "population": "Adults with insomnia or poor sleep",
    "results_summary": "This systematic review and meta-analysis evaluated valerian preparations in adults with insomnia or poor sleep. Results showed that mixed results with small benefits and methodological heterogeneity; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Valerian for sleep: a systematic review and meta-analysis.” PubMed, 2006, https://pubmed.ncbi.nlm.nih.gov/17145239/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/17145239/"
  },
  {
    "title": "Standardized Extract of Valeriana officinalis Improves Sleep Quality in Young Adults",
    "year": 2024,
    "study_type": "Randomized double-blind placebo-controlled trial",
    "population": "Young adults with mild insomnia",
    "results_summary": "This randomized double-blind trial evaluated valeriana officinalis standardized extract in young adults with mild insomnia. Results showed that improvements in sleep latency, efficiency, and total sleep time versus placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Standardized Extract of Valeriana officinalis Improves Sleep Quality in Young Adults.” PubMed, 2024, https://pubmed.ncbi.nlm.nih.gov/37899385/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/37899385/"
  },
  {
    "title": "A randomized clinical trial of valerian fails to improve self-reported sleep in older women with insomnia",
    "year": 2009,
    "study_type": "Randomized double-blind placebo-controlled trial",
    "population": "Older women with insomnia",
    "results_summary": "This randomized double-blind trial evaluated valerian in older women with insomnia. Results showed that no significant improvement compared with placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“A randomized clinical trial of valerian fails to improve self-reported sleep in older women with insomnia.” PubMed, 2009, https://pubmed.ncbi.nlm.nih.gov/18482867/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/18482867/"
  },
  {
    "title": "Efficacy of valerian–hops combination in primary insomnia",
    "year": 2005,
    "study_type": "Randomized double-blind placebo-controlled trial",
    "population": "Adults with primary insomnia",
    "results_summary": "This randomized double-blind trial evaluated valerian–hops combination in adults with primary insomnia. Results showed that improved sleep quality compared with placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Efficacy of valerian–hops combination in primary insomnia.” PubMed, 2005, https://pubmed.ncbi.nlm.nih.gov/16131285/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/16131285/"
  },
  {
    "title": "Valerian in benzodiazepine withdrawal: randomized trial",
    "year": 2006,
    "study_type": "Randomized double-blind trial",
    "population": "Adults discontinuing benzodiazepines",
    "results_summary": "This randomized double-blind trial evaluated valerian in adults discontinuing benzodiazepines. Results showed that no significant facilitation of withdrawal compared with placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Valerian in benzodiazepine withdrawal: randomized trial.” PubMed, 2006, https://pubmed.ncbi.nlm.nih.gov/16634474/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/16634474/"
  },
  {
    "title": "Valerian for insomnia: a systematic review of randomized clinical trials",
    "year": 2000,
    "study_type": "Systematic review of RCTs",
    "population": "Adults with insomnia",
    "results_summary": "This systematic review of rcts evaluated valerian in adults with insomnia. Results showed that inconclusive evidence and need for more rigorous trials; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Valerian for insomnia: a systematic review of randomized clinical trials.” PubMed, 2000, https://pubmed.ncbi.nlm.nih.gov/10767649/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/10767649/"
  },
  {
    "title": "Valerian and sleep quality: randomized crossover trial",
    "year": 2002,
    "study_type": "Randomized double-blind crossover trial",
    "population": "Healthy adults with self-reported sleep problems",
    "results_summary": "This randomized double-blind crossover trial evaluated valerian in healthy adults with self-reported sleep problems. Results showed that small improvements in sleep latency and quality; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Valerian and sleep quality: randomized crossover trial.” PubMed, 2002, https://pubmed.ncbi.nlm.nih.gov/12117838/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/12117838/"
  },
  {
    "title": "Valerian in restless legs syndrome: pilot RCT",
    "year": 2009,
    "study_type": "Randomized double-blind placebo-controlled pilot",
    "population": "Adults with restless legs syndrome",
    "results_summary": "This randomized double-blind pilot trial evaluated valerian in adults with restless legs syndrome. Results showed that trends toward improved sleep and symptom severity; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Valerian in restless legs syndrome: pilot RCT.” PubMed, 2009, https://pubmed.ncbi.nlm.nih.gov/19302744/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/19302744/"
  },
  {
    "title": "Comparison of valerian extract and oxazepam in the treatment of insomnia",
    "year": 2002,
    "study_type": "Randomized double-blind controlled trial",
    "population": "Adults with insomnia",
    "results_summary": "This randomized double-blind controlled trial evaluated valerian extract versus oxazepam in adults with insomnia. Results showed that comparable improvements on sleep measures with fewer side effects; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Comparison of valerian extract and oxazepam in the treatment of insomnia.” PubMed, 2002, https://pubmed.ncbi.nlm.nih.gov/12462022/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/12462022/"
  },
  {
    "title": "Valerian safety: review of adverse effects and interactions",
    "year": 2011,
    "study_type": "Narrative safety review",
    "population": "Adults using valerian products",
    "results_summary": "This narrative safety review evaluated valerian in adults using valerian products. Results showed that generally safe with mild adverse effects and caution advised with CNS depressants; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Valerian safety: review of adverse effects and interactions.” PubMed, 2011, https://pubmed.ncbi.nlm.nih.gov/21194372/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/21194372/"
  }
]